VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit. Oncotarget. 2014 Apr 15; 5(7):1837-45.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Disease-Free Survival
DNA Mutational Analysis
DNA, Neoplasm
Esophageal Neoplasms
Esophagogastric Junction
Female
Gene Amplification
Humans
Male
Middle Aged
Mutation
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Stomach Neoplasms
Survival Rate
authors with profiles
JAFFER A AJANI
SIQING FU
STANLEY R HAMILTON
FUNDA MERIC-BERNSTAM
DAVID SANGHYUN HONG
SARINA ANNE PIHA-PAUL
VIVEK SUBBIAH
FILIP JANKU